These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 11854231)

  • 1. Intranasal immunization with pneumococcal conjugate vaccines with LT-K63, a nontoxic mutant of heat-Labile enterotoxin, as adjuvant rapidly induces protective immunity against lethal pneumococcal infections in neonatal mice.
    Jakobsen H; Bjarnarson S; Del Giudice G; Moreau M; Siegrist CA; Jonsdottir I
    Infect Immun; 2002 Mar; 70(3):1443-52. PubMed ID: 11854231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranasal immunization with pneumococcal polysaccharide conjugate vaccines with nontoxic mutants of Escherichia coli heat-labile enterotoxins as adjuvants protects mice against invasive pneumococcal infections.
    Jakobsen H; Schulz D; Pizza M; Rappuoli R; Jónsdóttir I
    Infect Immun; 1999 Nov; 67(11):5892-7. PubMed ID: 10531245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The adjuvant LT-K63 can restore delayed maturation of follicular dendritic cells and poor persistence of both protein- and polysaccharide-specific antibody-secreting cells in neonatal mice.
    Bjarnarson SP; Adarna BC; Benonisson H; Del Giudice G; Jonsdottir I
    J Immunol; 2012 Aug; 189(3):1265-73. PubMed ID: 22753937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the antibody response to pneumococcal glycoconjugates and the effect of heat-labile enterotoxin on IGg subclasses after intranasal immunization.
    Jakobsen H; Adarna BC; Schulz D; Rappuoli R; Jonsdottir I
    J Infect Dis; 2001 May; 183(10):1494-500. PubMed ID: 11319685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The advantage of mucosal immunization for polysaccharide-specific memory responses in early life.
    Bjarnarson SP; Jakobsen H; Del Giudice G; Trannoy E; Siegrist CA; Jonsdottir I
    Eur J Immunol; 2005 Apr; 35(4):1037-45. PubMed ID: 15756644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IC31, a two-component novel adjuvant mixed with a conjugate vaccine enhances protective immunity against pneumococcal disease in neonatal mice.
    Olafsdottir TA; Lingnau K; Nagy E; Jonsdottir I
    Scand J Immunol; 2009 Mar; 69(3):194-202. PubMed ID: 19281531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early life T cell responses to pneumococcal conjugates increase with age and determine the polysaccharide-specific antibody response and protective efficacy.
    Jakobsen H; Hannesdottir S; Bjarnarson SP; Schulz D; Trannoy E; Siegrist CA; Jonsdottir I
    Eur J Immunol; 2006 Feb; 36(2):287-95. PubMed ID: 16385627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvants Enhance the Induction of Germinal Center and Antibody Secreting Cells in Spleen and Their Persistence in Bone Marrow of Neonatal Mice.
    Aradottir Pind AA; Dubik M; Thorsdottir S; Meinke A; Harandi AM; Holmgren J; Del Giudice G; Jonsdottir I; Bjarnarson SP
    Front Immunol; 2019; 10():2214. PubMed ID: 31616417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranasal immunization with SAG1 and nontoxic mutant heat-labile enterotoxins protects mice against Toxoplasma gondii.
    Bonenfant C; Dimier-Poisson I; Velge-Roussel F; Buzoni-Gatel D; Del Giudice G; Rappuoli R; Bout D
    Infect Immun; 2001 Mar; 69(3):1605-12. PubMed ID: 11179334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of LT-K63 and CpG2006 on phenotype and function of murine neonatal lymphoid cells.
    Olafsdottir TA; Hannesdottir SG; Giudice GD; Trannoy E; Jonsdottir I
    Scand J Immunol; 2007 Oct; 66(4):426-34. PubMed ID: 17850587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal immunization with pneumococcal polysaccharide conjugate vaccines protects mice against invasive pneumococcal infections.
    Jakobsen H; Saeland E; Gizurarson S; Schulz D; Jónsdóttir I
    Infect Immun; 1999 Aug; 67(8):4128-33. PubMed ID: 10417183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Strategy To Protect against Influenza Virus-Induced Pneumococcal Disease without Interfering with Commensal Colonization.
    Greene CJ; Marks LR; Hu JC; Reddinger R; Mandell L; Roche-Hakansson H; King-Lyons ND; Connell TD; Hakansson AP
    Infect Immun; 2016 Jun; 84(6):1693-1703. PubMed ID: 27001538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective levels of polysaccharide-specific maternal antibodies may enhance the immune response elicited by pneumococcal conjugates in neonatal and infant mice.
    Richter MY; Jakobsen H; Haeuw JF; Power UF; Jonsdottir I
    Infect Immun; 2005 Feb; 73(2):956-64. PubMed ID: 15664938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neonatal immune response and serum bactericidal activity induced by a meningococcal conjugate vaccine is enhanced by LT-K63 and CpG2006.
    Brynjolfsson SF; Bjarnarson SP; Mori E; Del Giudice G; Jonsdottir I
    Vaccine; 2008 Aug; 26(35):4557-62. PubMed ID: 18597905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sublingually administered Bacillus subtilis cells expressing tetanus toxin C fragment induce protective systemic and mucosal antibodies against tetanus toxin in mice.
    Amuguni JH; Lee S; Kerstein KO; Brown DW; Belitsky BR; Herrmann JE; Keusch GT; Sonenshein AL; Tzipori S
    Vaccine; 2011 Jun; 29(29-30):4778-84. PubMed ID: 21565244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization of female mice with glycoconjugates protects their offspring against encapsulated bacteria.
    Richter MY; Jakobsen H; Birgisdottir A; Haeuw JF; Power UF; Del Giudice G; Bartoloni A; Jonsdottir I
    Infect Immun; 2004 Jan; 72(1):187-95. PubMed ID: 14688096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcutaneous immunization using colonization factor and heat-labile enterotoxin induces correlates of protective immunity for enterotoxigenic Escherichia coli.
    Yu J; Cassels F; Scharton-Kersten T; Hammond SA; Hartman A; Angov E; Corthésy B; Alving C; Glenn G
    Infect Immun; 2002 Mar; 70(3):1056-68. PubMed ID: 11854183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of protective efficacy following intranasal immunization with vaccine plus a nontoxic LTK63 mutant delivered with nanoparticles.
    Baudner BC; Balland O; Giuliani MM; Von Hoegen P; Rappuoli R; Betbeder D; Del Giudice G
    Infect Immun; 2002 Sep; 70(9):4785-90. PubMed ID: 12183520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucosal immunoadjuvant activity of recombinant Escherichia coli heat-labile enterotoxin and its B subunit: induction of systemic IgG and secretory IgA responses in mice by intranasal immunization with influenza virus surface antigen.
    Verweij WR; de Haan L; Holtrop M; Agsteribbe E; Brands R; van Scharrenburg GJ; Wilschut J
    Vaccine; 1998 Dec; 16(20):2069-76. PubMed ID: 9796066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mucosal adjuvanticity of two nontoxic mutants of Escherichia coli heat-labile enterotoxin varies with immunization routes.
    Park EJ; Chang JH; Kim JS; Yum JS; Chung SI
    Exp Mol Med; 2000 Jun; 32(2):72-8. PubMed ID: 10926118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.